This is the first time in six quarters that both Neupogen and Epogen have done better than expected," said Jay Silverman, an analyst with Wertheim Schroder of New York

Gregg Gonsalves, a member of the New York-based Treatment Action Group (TAG), an AIDS activist organization that is represented on the NTFADD, told BioWorld that many activists are skeptical of task forces

David Webber, an analyst with Alex, Brown & Sons Inc., of New York, said suspension of the Antril program ends Synergen's hopes of becoming a major independent drug company

Cortech also has completed a royalty buyout for CE-1037 from the Research Foundation of the State University of New York

of New York and Bain Capital Inc

Ron Wyden (D-Ore.), a year-old study of drug prices done by a consumer group got a burst of new life _ stories on the report appeared in The Washington Post and The New York Times

Paramount Capital of New York managed the placement, which included investments from U.S. Healthcare Inc

Applied Microbiology, of New York, has a similar deal with Astra/Merck, a New York-based subsidiary of Merck & Co., to develop an application of Ambicin for the treatment of helicobacter pylori bacterium, which has been linked to peptic ulcers

Innovir Labs Ribozyme WO 94/13791, 833 New York target inactivation Ribozyme gene expression controlled by ligand-binding sequence

Harold Ginsberg, Columbia University, New York: RAC

and Lehman Brothers, both of New York, and Cowen & Co., of Boston

Innovir Laboratories Inc., of New York, named Paul Leibowitz senior vice president

of New York, underwrote the offering

Applied Microbiology Inc., of New York, appointed Peter Blackburn president and chief operating officer

Laurence Silverman, partner with Cahill Gordon & Reindel in New York and lead counsel for Xoma in both of its securities suits, said the courts are more willing to scrutinize these types of lawsuits for merit than they were just five years ago...We're seeing a trend in more sophisticated jurisdictions, such as San Francisco, New York and Boston, for the courts to take a much closer look at the motion-to-dismiss stage," Silverman told BioWorld

By securing rights to Rhone-Poulenc's pending patents, Rabney said ImClone, of New York, intends to develop the use of C225 in association with chemotherapy treatments

The company was founded by cell cycle researchers David Beach, of Cold Spring Harbor, an independent research foundation in New York, who is now on the company's scientific board

Lazzarini, who directs the Brookdale Center for Molecular Biology at New York's Mt

Immunologic EPO 600 591 New York tumor killing Tumor cells engineered to express B7 surface protein...Fabry disease WO 94/12628 New York treatment Making human-galactosidase A with transfected eukaryotic host